(Q44542780)
Statements
Cetuximab plus irinotecan in heavily pretreated metastatic colorectal cancer progressing on irinotecan: MABEL Study (English)
Hansjochen Wilke
Robert Glynne-Jones
Josef Thaler
Antoine Adenis
Peter Preusser
Enrique Aranda Aguilar
Matti S Aapro
Regina Esser